Premarket Mover: Editas Medicine Inc (EDIT) Up 2.06%

Editas Medicine Inc (EDIT) has gained Tuesday morning, with the stock adding 2.06% in pre-market trading to 59.4. EDIT's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Editas Medicine Inc ranks higher than 87% of stocks. Editas Medicine Inc has fallen 3.61% over the past month, closing at $64.72 on August 24. During this period of time, the stock fell as low as $58.20 and as high as $73.03. EDIT has an average analyst recommendation of Buy. The company has an average price target of $57.44.

EDIT has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on EDIT!

See Full EDIT Report

Editas Medicine Inc has a Long-Term Technical rank of 68. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 32% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, EDIT ranks better than 84% of stocks.

Important Dates for Investors in EDIT:

-Editas Medicine Inc is set to release earnings on 11/2/2021. During their last earnings release the company posted EPS of $-2.60. -We do not have a set dividend date for Editas Medicine Inc at this time. Click Here To Get The Full Report on Editas Medicine Inc (EDIT)